Free Trial

NeuroBo Pharmaceuticals (NRBO) SEC Filings & 10K Form

NeuroBo Pharmaceuticals logo
$2.37 -0.03 (-1.25%)
(As of 11:30 AM ET)

Recent NeuroBo Pharmaceuticals SEC Filings

DateFilerForm TypeView
11/18/2024
7:35 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2024
7:01 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2024
6:00 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
7:07 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
3:20 PM
DONG-A ST CO., LTD (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
3:10 PM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
7:01 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
7:00 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form PRE 14A
07/30/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2024
11:15 PM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form EFFECT
07/24/2024
4:11 PM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 424B3
07/18/2024
7:21 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
07/16/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
10:11 AM
DONG-A ST CO., LTD (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
Form 4/A
06/26/2024
8:15 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
3:15 PM
DONG-A ST CO., LTD (Filed by)
NeuroBo Pharmaceuticals, Inc. (Subject)
NeuroBo Pharmaceuticals (Subject)
Form SC 13D/A
06/25/2024
3:16 PM
DONG-A ST CO., LTD (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
7:21 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 424B5
06/25/2024
7:00 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2024
5:01 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
6:24 PM
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
Tursi James Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:24 PM
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
STRICKLAND D GORDON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:25 PM
Glickman Mark A (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:25 PM
KOVEN ANDREW I (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:26 PM
GROVES JASON L (Reporting)
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:26 PM
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
Salsbury Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
8:00 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
7:05 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2024
7:41 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form DEF 14A
04/30/2024
7:42 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form ARS
04/30/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2024
11:15 PM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form EFFECT
04/17/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2024
3:30 PM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
7:01 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2024
8:20 PM
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
Woodworth Marshall H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Trump said you could learn something from this man (Ad)

Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement.

Here’s everything you need to know.
03/04/2024
6:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/29/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
7:52 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/01/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/18/2024
7:30 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2024
7:45 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2023
8:00 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2023
8:03 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2023
8:20 AM
NeuroBo Pharmaceuticals, Inc. (Filer)
NeuroBo Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2023
4:12 PM
NeuroBo Pharmaceuticals, Inc. (Issuer)
NeuroBo Pharmaceuticals (Issuer)
Tursi James Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NRBO) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners